Thalidomide: current and potential clinical applications.
about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsAntitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice.Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study.Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countriesNon-conventional humanitarian interventions on Ebola outbreak crisis in West Africa: health, ethics and legal implicationsPhase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508.Thalidomide-a notorious sedative to a wonder anticancer drug.Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cellsNovel approaches to Behçet's disease.Targeting the TNF-alpha pathway in sarcoidosis.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Thalidomide: the tragedy of birth defects and the effective treatment of disease.Update on therapy--thalidomide in the treatment of lupus.The treatment of chronic recurrent oral aphthous ulcers.Thalidomide use in pediatric patients.Small therapeutic molecules for the treatment of inflammatory bowel diseasePerspectives for TNF-alpha-targeting therapies.Emerging role of anti-tumor necrosis factor therapy in rheumatic diseasesThalidomide prevents the progression of peritoneal fibrosis in mice.Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases.Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis.Thalidomide for erythema nodosum leprosum and other applications.Advances in molecular therapies in patients with brain tumors.Immunotherapy for autoimmune and inflammatory renal diseases.Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide.Thalidomide in dermatology: revisited.Thalidomide inhibits alternative activation of macrophages in vivo and in vitro: a potential mechanism of anti-asthmatic effect of thalidomideImmunological consequences of thalidomide treatment in Sjögren's syndromeUse of thalidomide in the management of three HIV seroreactive children with Kaposi's sarcoma referred for palliative care.New sources of drugs for hematologic malignanciesIn vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems.Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide.Salvage therapy for hepatocellular carcinoma with thalidomide.Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients.Angiogenesis is an independent prognostic factor in malignant mesothelioma.Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates.The effects of thalidomide and minocycline on taxol-induced hyperalgesia in ratsPomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.
P2860
Q22242050-4251D7A2-D5A4-4244-B696-8C6EF2015AFDQ24791211-D2F9938F-74D5-44F5-99F0-75AD7388D378Q24812750-78ABD038-AFAA-4608-93ED-71A1FBC6F910Q28538338-763CBAA8-CFD0-404A-BEE5-388FE6852694Q30204769-6A70FEB9-8457-4554-BE81-C5C34B608922Q33611998-217F67A0-CDF3-4F03-ADC4-69E62CBCEED0Q33956871-C7A969C8-7B78-4426-AED3-DB12B4F1258DQ33986673-58FE6510-CD48-49D1-9D61-3A298FB55C31Q34075044-8EB85C53-F411-483B-A48A-9A03931A172FQ34087381-8EE2F5C7-A735-46A4-9630-4B9CBD1A92C4Q34152778-260DDE6C-AA76-4BDE-AD9B-8F1538ED5D63Q34179690-3E1A3E08-15F2-470D-9CBB-8BFEB197EEF2Q34227018-B2B8F753-65A8-467F-A968-7F8D4D66F13FQ34430267-CA0D8D1B-05E2-4FB5-866E-346F977D808EQ34564331-9B4FB1E4-238A-4C49-81D7-8614CE427712Q34600992-84C7E53C-0CE7-42BD-8645-CE09D30C3740Q34731078-CE777CF5-199B-41B8-ABF2-AD0486C7E9F8Q34731307-790E9DAF-0DFB-4A5B-A460-CF7DBA565345Q34985928-4D11448B-425B-41A7-8DBA-15C63A9C392CQ34989354-6A857A2B-AF82-4FE6-B80E-C45D2E0425D2Q35062816-493C42FB-9139-4E02-B6F3-ECA80564757BQ35074047-92AD3780-6A31-408C-A424-310D14DEC18EQ35101473-A4AE7266-371F-4F96-ADD5-976C3804E346Q35113656-8EB5DD0F-4BF2-492C-826D-E29A9EA2DB05Q35144046-FF2A1808-F5C3-43E5-A6D1-B5D45DBC0C99Q35166127-F36A8240-E885-4AFD-911C-6F9901EA8489Q35215252-88812F09-2067-4FFE-9A9F-D17B78376122Q35532761-90A1CC4E-5C6A-4FAD-A1EB-619790F284EDQ35636539-DE3F534D-E5EB-4E32-8DD0-A081611ADB59Q35938303-D8C8EB0B-7E91-4A58-931A-F53E25D530F6Q35979113-BD414FF4-2F03-4236-BF7D-4BB59870FB85Q36001001-03B1D66C-CADA-40FD-ABE8-0D47421983F8Q36168669-F764A134-FB59-43DC-B030-8DEAB5584FF6Q36474106-736B6BAA-370A-432A-B79E-A3D95A4E2610Q36516943-8E14A6AC-CF0E-43A9-BEAF-9874B7D1F0B5Q36643416-822C8421-BD80-4873-9D9C-A4C781E3627DQ36936541-D4876FFF-DA98-4D18-85F0-BD58232195A8Q36959362-CAFCBECC-4BF0-4E0D-89DD-A48C0A19A3AFQ37045248-A00CBF59-BFA6-4FB3-AA28-B70389D5906AQ37406600-79FE5374-917E-4E2A-AB28-A4328D8C7241
P2860
Thalidomide: current and potential clinical applications.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Thalidomide: current and potential clinical applications.
@ast
Thalidomide: current and potential clinical applications.
@en
type
label
Thalidomide: current and potential clinical applications.
@ast
Thalidomide: current and potential clinical applications.
@en
prefLabel
Thalidomide: current and potential clinical applications.
@ast
Thalidomide: current and potential clinical applications.
@en
P1476
Thalidomide: current and potential clinical applications.
@en
P2093
Calabrese L
Fleischer AB
P304
P356
10.1016/S0002-9343(99)00408-8
P407
P577
2000-04-01T00:00:00Z